申请人:Streicher Ruediger
公开号:US20050014810A1
公开(公告)日:2005-01-20
The present invention relates to the use of a substituted 2-phenylbenzimidazole of formula I
wherein R
1
, R
2
, R
3
, R
4
, R
5
and m have the meanings given in the claims, for the preparation of a medicament for the treatment or prevention of diseases involving glucagon receptors, as well as new compounds of formula I wherein R
1
is a group of formula
本发明涉及使用式I的取代2-苯基苯并咪唑,其中R1、R2、R3、R4、R5和m具有权利要求中给出的含义,用于制备治疗或预防涉及胰高血糖素受体疾病的药物,以及式I的新化合物,其中R1是一个公式的基团。